Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Asset Writedowns and Impairment (2011)

Iqvia Holdings' (IQV) quarterly Asset Writedowns and Impairment came in at $12.2 million in Q4 2011.

Analysis

Iqvia Holdings (IQV) Asset Writedowns and Impairment (2011) Analysis & Trends

Iqvia Holdings has disclosed Asset Writedowns and Impairment across 1 years of filings, most recently posting $12.2 million for Q4 2011.

  • In Q4 2011, Asset Writedowns and Impairment changed N/A year-over-year to $12.2 million; the TTM figure through Dec 2017 stood at $12.2 million (changed N/A YoY), while the FY2017 annual figure was $40.0 million, up 42.86% from the prior year.
  • Asset Writedowns and Impairment came in at $12.2 million for Q4 2011 at Iqvia Holdings.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $12.2 million in Q4 2011 to a low of $12.2 million in Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 12.20 Mn